NCT06239220 2026-02-27PD-L1 t-haNK, NAI IL-15sa and Cetuximab for Recurrent, Metastatic HNSCCDana-Farber Cancer InstitutePhase 2 Recruiting25 enrolled
NCT01875601 2026-02-17NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid TumorsNational Institutes of Health Clinical Center (CC)Phase 1 Completed16 enrolled